Skip to main content
. 2021 Jul 23;43(5):2595–2609. doi: 10.1007/s11357-021-00418-x

Table 6.

Median RLS (95% confidence intervals), number of cells dissected (n), percent change, and p-value (Wilcoxon rank-sum test, Bonferroni-corrected for multiple testing within each dose response) of natural products compared to vehicle control. Note: separate control used for each compound. Berberine suspended in H2O and thus compared to YPD

Treatment Concentration n Median RLS (95% CI) % change Bonferroni-corrected p-value
YPD NA 160 21.5 (20–23) - -
Berberine 1 µg/mL 155 22 (21–25) 2.3 0.173
Berberine 10 µg/mL 160 21 (20–23)  − 2.3 1
Berberine 50 µg/mL 157 10 (9–11)  − 53.5  < 0.001
DMSO 1% 60 23.5 (21–30) - -
Celastrol 5 µM 60 24.5 (22–29) 4.3 1
Celastrol 10 µM 60 25 (23–29) 6.4 1
Celastrol 100 µM 60 23 (18–28)  − 2.1 0.841